Skip to main content

Table 1 Comparison of Clinical Data

From: Combined detection of circulating tumor cells, α-fetoprotein heterogene-3 and α-fetoprotein in the early diagnosis of HCC for the prediction of efficacy, prognosis, recurrence after microwave ablation

Indexes

Normal control group (n = 110)

Hepatitis group (n = 127)

Cirrhosis group (n = 102)

HCC group (n = 143)

P

Age (years)

49.4(41.2-60.7)

48.6(37.9-61.2)

51.3(42.2-63.5)

57.8(46.3-67.6)

<0.001

Sex (n, %)

 Male

63(57.27)

70(55.12)

59(57.84)

91(63.64)

>0.05

 Female

47(42.73)

57(44.88)

43(42.16)

52(36.36)

 

ALT (U/L)

19.6(13.2-26.8)

30.2(21.6-50.9)

43.7(30.7-64.2)

70.3(40.1-115.4)

<0.001

AST (U/L)

16.3(10.1-23.5)

27.1(19.5-46.3)

40.2(26.0-59.1)

55.1(36.8-90.6)

<0.001

GGT (U/L)

17.1(12.5-30.1)

24.4(17.9-31.4)

36.0(27.2-43.5)

98.6(41.2-167.8)

<0.001

TBIL (μmol/L)

12.6(9.3-16.7)

18.2(13.0-25.6)

25.3(18.1-33.2)

35.1(20.9-58.3)

<0.001

DBIL (μmol/L)

5.1(3.7-7.3)

7.0(5.1-11.2)

10.4(7.2-12.8)

15.7(12.1-27.7)

<0.001

ALB (g/L)

43.7(41.2-46.1)

43.3(38.9-45.6)

37.6(33.7-39.6)

32.4(28.7-37.5)

<0.001

Plt (109/L)

214.2(180.3-242.7)

196.5(174.2-219.5)

158.3(127.5-177.0)

129.7(93.8-151.6)

<0.001

WBC (109/L)

5.7(5.0-6.4)

5.5(4.9-6.2)

4.3(3.1-5.2)

4.1(2.9-5.1)

<0.001

RBC (1012/L)

4.8(4.3-5.1)

4.7(4.2-5.2)

3.8(2.9-4.2)

3.2(2.5-3.8)

<0.001

Hb (g/L)

145.9(134.8-153.9)

141.7(130.2-150.6)

112.6(96.7-125.1)

90.7(72.7-115.1)

<0.001

  1. Abbreviations:ALB albumin, ALT alanine aminotransferase, AST aspartate aminotransferase, DBIL direct bilirubin, GGT gamma-glutamyl transferase, Hb hemoglobin, Plt Platelets, RBC red blood cells, TBIL total direct and indirect bilirubin, WBC white blood cells